Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis

Rheumatology (Oxford). 2008 May;47(5):738-9. doi: 10.1093/rheumatology/ken113. Epub 2008 Mar 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / therapeutic use*
  • Antitubercular Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / microbiology
  • Female
  • Humans
  • Middle Aged
  • Mycobacterium tuberculosis*
  • Rituximab
  • Tuberculosis / complications
  • Tuberculosis / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Antitubercular Agents
  • Tumor Necrosis Factor-alpha
  • Rituximab